Clover Health Investments, Corp. (NASDAQ:CLOV) Short Interest Down 8.2% in January

Clover Health Investments, Corp. (NASDAQ:CLOV) was the recipient of a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 15,080,000 shares, a decline of 8.2% from the January 15th total of 16,420,000 shares. Based on an average trading volume of 6,160,000 shares, the short-interest ratio is currently 2.4 days.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in Clover Health Investments by 2.0% in the 4th quarter. Vanguard Group Inc. now owns 19,585,213 shares of the company’s stock valued at $61,693,000 after purchasing an additional 386,499 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Clover Health Investments by 1.1% in the fourth quarter. Geode Capital Management LLC now owns 4,882,461 shares of the company’s stock valued at $15,387,000 after buying an additional 53,760 shares in the last quarter. Marshall Wace LLP grew its holdings in Clover Health Investments by 167.6% during the fourth quarter. Marshall Wace LLP now owns 3,769,765 shares of the company’s stock worth $11,875,000 after acquiring an additional 2,360,902 shares during the period. Charles Schwab Investment Management Inc. raised its position in Clover Health Investments by 5.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 3,000,505 shares of the company’s stock worth $8,461,000 after acquiring an additional 150,550 shares in the last quarter. Finally, State Street Corp lifted its holdings in Clover Health Investments by 65.0% in the third quarter. State Street Corp now owns 2,189,380 shares of the company’s stock valued at $6,174,000 after acquiring an additional 862,621 shares during the period. 19.77% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Craig Hallum started coverage on Clover Health Investments in a research report on Tuesday, December 17th. They set a “buy” rating and a $6.00 price objective for the company.

Clover Health Investments Stock Performance

Shares of CLOV opened at $4.42 on Wednesday. The stock has a market capitalization of $2.21 billion, a P/E ratio of -22.07 and a beta of 1.99. Clover Health Investments has a 1 year low of $0.61 and a 1 year high of $4.87. The company’s fifty day moving average is $3.85 and its two-hundred day moving average is $3.46.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.